These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 26181816)

  • 1. Brief Report: Does Most Mortality in Patients on ART Occur in Care or After Lost to Follow-Up? Evidence From the Themba Lethu Clinic, South Africa.
    Budgell EP; Maskew M; Long L; Sanne I; Fox MP
    J Acquir Immune Defic Syndr; 2015 Nov; 70(3):323-8. PubMed ID: 26181816
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Markers of poor adherence among adults with HIV attending Themba Lethu HIV Clinic, Helen Joseph Hospital, Johannesburg, South Africa.
    Nnambalirwa M; Govathson C; Evans D; McNamara L; Maskew M; Nyasulu P
    Trans R Soc Trop Med Hyg; 2016 Dec; 110(12):696-704. PubMed ID: 28938050
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Twelve-year mortality in adults initiating antiretroviral therapy in South Africa.
    Cornell M; Johnson LF; Wood R; Tanser F; Fox MP; Prozesky H; Schomaker M; Egger M; Davies MA; Boulle A;
    J Int AIDS Soc; 2017 Sep; 20(1):21902. PubMed ID: 28953328
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The social and clinical characteristics of patients on antiretroviral therapy who are 'lost to follow-up' in KwaZulu-Natal, South Africa: a prospective study.
    Peltzer K; Ramlagan S; Khan MS; Gaede B
    SAHARA J; 2011; 8(4):179-86. PubMed ID: 23236959
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence and predictors of herpes zoster among antiretroviral therapy-naïve patients initiating HIV treatment in Johannesburg, South Africa.
    Shearer K; Maskew M; Ajayi T; Berhanu R; Majuba P; Sanne I; Fox MP
    Int J Infect Dis; 2014 Jun; 23():56-62. PubMed ID: 24680820
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcomes of Nigeria's HIV/AIDS Treatment Program for Patients Initiated on Antiretroviral Treatment between 2004-2012.
    Dalhatu I; Onotu D; Odafe S; Abiri O; Debem H; Agolory S; Shiraishi RW; Auld AF; Swaminathan M; Dokubo K; Ngige E; Asadu C; Abatta E; Ellerbrock TV
    PLoS One; 2016; 11(11):e0165528. PubMed ID: 27829033
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Using vital registration data to update mortality among patients lost to follow-up from ART programmes: evidence from the Themba Lethu Clinic, South Africa.
    Fox MP; Brennan A; Maskew M; MacPhail P; Sanne I
    Trop Med Int Health; 2010 Apr; 15(4):405-13. PubMed ID: 20180931
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss to care and death before antiretroviral therapy in Durban, South Africa.
    Bassett IV; Wang B; Chetty S; Mazibuko M; Bearnot B; Giddy J; Lu Z; Losina E; Walensky RP; Freedberg KA
    J Acquir Immune Defic Syndr; 2009 Jun; 51(2):135-9. PubMed ID: 19504725
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retention and mortality outcomes from a community-supported public-private HIV treatment programme in Myanmar.
    Mburu G; Paing AZ; Myint NN; Di W; Thu KH; Ram M; Hoffmann CJ; Wang B; Naing S
    J Int AIDS Soc; 2016; 19(1):20926. PubMed ID: 27784509
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictors of dropout from care among HIV-infected patients initiating antiretroviral therapy at a public sector HIV treatment clinic in sub-Saharan Africa.
    Asiimwe SB; Kanyesigye M; Bwana B; Okello S; Muyindike W
    BMC Infect Dis; 2016 Feb; 16():43. PubMed ID: 26832737
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcomes of the Botswana national HIV/AIDS treatment programme from 2002 to 2010: a longitudinal analysis.
    Farahani M; Vable A; Lebelonyane R; Seipone K; Anderson M; Avalos A; Chadborn T; Tilahun H; Roumis D; Moeti T; Musuka G; Busang L; Gaolathe T; Malefho KC; Marlink R
    Lancet Glob Health; 2014 Jan; 2(1):e44-50. PubMed ID: 25104635
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pediatric Access and Continuity of HIV Care Before the Start of Antiretroviral Therapy in Sub-Saharan Africa.
    Bastard M; Poulet E; Nicolay N; Szumilin E; Balkan S; Pujades-Rodriguez M
    Pediatr Infect Dis J; 2016 Sep; 35(9):981-6. PubMed ID: 27187757
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of community- versus clinic-based adherence clubs on loss from care and viral suppression for antiretroviral therapy patients: Findings from a pragmatic randomized controlled trial in South Africa.
    Hanrahan CF; Schwartz SR; Mudavanhu M; West NS; Mutunga L; Keyser V; Bassett J; Van Rie A
    PLoS Med; 2019 May; 16(5):e1002808. PubMed ID: 31112543
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The relation between efavirenz versus nevirapine and virologic failure in Johannesburg, South Africa.
    Shearer K; Brennan AT; Maskew M; Long L; Berhanu R; Sanne I; Fox MP
    J Int AIDS Soc; 2014; 17(1):19065. PubMed ID: 25361827
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The importance of clinic attendance in the first six months on antiretroviral treatment: a retrospective analysis at a large public sector HIV clinic in South Africa.
    Brennan AT; Maskew M; Sanne I; Fox MP
    J Int AIDS Soc; 2010 Dec; 13():49. PubMed ID: 21134297
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predicting death and lost to follow-up among adults initiating antiretroviral therapy in resource-limited settings: Derivation and external validation of a risk score in Haiti.
    McNairy ML; Jannat-Khah D; Pape JW; Marcelin A; Joseph P; Mathon JE; Koenig S; Wells M; Fitzgerald DW; Evans A
    PLoS One; 2018; 13(8):e0201945. PubMed ID: 30157197
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Seven-year experience of a primary care antiretroviral treatment programme in Khayelitsha, South Africa.
    Boulle A; Van Cutsem G; Hilderbrand K; Cragg C; Abrahams M; Mathee S; Ford N; Knight L; Osler M; Myers J; Goemaere E; Coetzee D; Maartens G
    AIDS; 2010 Feb; 24(4):563-72. PubMed ID: 20057311
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early mortality among children and adults in antiretroviral therapy programs in Southwest Ethiopia, 2003-15.
    Gesesew HA; Ward P; Woldemichael K; Mwanri L
    PLoS One; 2018; 13(6):e0198815. PubMed ID: 29912974
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characteristics and outcomes of adult patients lost to follow-up at an antiretroviral treatment clinic in johannesburg, South Africa.
    Dalal RP; Macphail C; Mqhayi M; Wing J; Feldman C; Chersich MF; Venter WD
    J Acquir Immune Defic Syndr; 2008 Jan; 47(1):101-7. PubMed ID: 17971708
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Initiating Antiretroviral Therapy for HIV at a Patient's First Clinic Visit: The RapIT Randomized Controlled Trial.
    Rosen S; Maskew M; Fox MP; Nyoni C; Mongwenyana C; Malete G; Sanne I; Bokaba D; Sauls C; Rohr J; Long L
    PLoS Med; 2016 May; 13(5):e1002015. PubMed ID: 27163694
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.